PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.
2026-10-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization
2026-10-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea
2026-10-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
EVIDENT Completes Acquisition of CrestOptics S.p.A.
2026-10-05T    Biotechnology   Computer/Electronics   Electronic Components   Health Care/Hospital 
Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers
2026-10-05T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)
2026-10-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Celaid Therapeutics Completes Second Close of Series B Financing Round
2026-10-05T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
2026-10-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
2026-10-04T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy
2026-10-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.